Future acceptance and promotion of telemedicine

In this Q&A session, Professor Andreas Meyer-Lindenberg (Germany) and Dr Gus Alva (USA) discuss the exciting opportunities associated with digital tools and explore the future role pharmaceutical companies can play in the promotion of telemedicine, through and beyond COVID-19.

This video forms part of a series of Q&A discussions from the Lundbeck-sponsored live webinar ‘How Technology Has Come to the Forefront in the Treatment of Mental Health’.

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country